StockNews.com Initiates Coverage on Sientra (NASDAQ:SIEN)

Equities researchers at StockNews.com initiated coverage on shares of Sientra (NASDAQ:SIEN) in a note issued to investors on Thursday. The brokerage set a “hold” rating on the medical instruments supplier’s stock.

Sientra Stock Performance

The stock has a 50-day moving average price of $0.46 and a two-hundred day moving average price of $1.18. The stock has a market capitalization of $2.08 million, a PE ratio of -0.03 and a beta of 2.04. Sientra has a 52 week low of $0.16 and a 52 week high of $4.94.

Institutional Trading of Sientra

A number of hedge funds and other institutional investors have recently modified their holdings of SIEN. BlackRock Inc. boosted its position in shares of Sientra by 2.0% during the first quarter. BlackRock Inc. now owns 3,768,538 shares of the medical instruments supplier’s stock worth $8,366,000 after acquiring an additional 74,896 shares during the last quarter. Vanguard Group Inc. boosted its position in shares of Sientra by 13.3% during the first quarter. Vanguard Group Inc. now owns 3,106,395 shares of the medical instruments supplier’s stock worth $6,896,000 after acquiring an additional 364,180 shares during the last quarter. Millennium Management LLC boosted its position in shares of Sientra by 253.4% during the second quarter. Millennium Management LLC now owns 1,989,323 shares of the medical instruments supplier’s stock worth $1,666,000 after acquiring an additional 1,426,343 shares during the last quarter. First Light Asset Management LLC boosted its position in shares of Sientra by 11.3% during the first quarter. First Light Asset Management LLC now owns 1,789,359 shares of the medical instruments supplier’s stock worth $3,972,000 after acquiring an additional 181,010 shares during the last quarter. Finally, State Street Corp boosted its position in shares of Sientra by 3.9% during the first quarter. State Street Corp now owns 1,018,410 shares of the medical instruments supplier’s stock worth $2,261,000 after acquiring an additional 38,403 shares during the last quarter. 15.38% of the stock is owned by hedge funds and other institutional investors.

Sientra Company Profile

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.